Hand Scleroderma Experience Survey for People With Systemic Sclerosis
Part of Skin clinical trials.
This study is testing a new scale to measure what it's like to live with hand problems caused by systemic sclerosis (scleroderma). By answering questions about your daily hand function, you can help doctors better understand your experience and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of systemic sclerosis (scleroderma) from a rheumatologist.
- You are 18 years old or older.
- You do not have any neurological disease that affects your hand function, such as a stroke or nerve injury.
- You do not have any bone or joint problems that affect your hand or arm function, and you have not had orthopedic surgery.
- You speak and understand Turkish fluently.
- You do not have a psychiatric condition that makes it hard for you to cooperate with study tasks.
- You do not have heart failure or lung disease that limits your daily activities.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at hand function and disability in people with systemic sclerosis who have digital ulcers. It aims to understand how these ulcers affect daily hand use.
This study is adapting a questionnaire to measure how scleroderma affects your daily life. Your responses will help make the tool more useful for Turkish-speaking patients.
This study looks at how scleroderma affects physical performance and daily function in children and adults. It aims to understand the impact of the disease on movement and everyday activities.
This study compares skin samples from people with scleroderma and healthy volunteers to understand what goes wrong in the skin. It may help researchers find new treatment targets.
This study tests a home-based exercise program to see if it improves quality of life for people with systemic sclerosis (scleroderma). You would do the exercises on your own, and researchers would check in with you using email questionnaires.
This study tests whether a person's own fat cells (processed into regenerative cells) can be injected into the hands to improve hand function and reduce skin thickening in systemic sclerosis (scleroderma). It’s designed for people whose hand problems are significant but not too severe.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.